Overview

A Short Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate the efficacy and safety of aripiprazole orally administered over a period of 8 weeks in pediatric patients with Autistic Disorder
Phase:
Phase 3
Details
Lead Sponsor:
Otsuka Pharmaceutical Co., Ltd.
Treatments:
Aripiprazole